Almirall SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Almirall (ALM)
Almirall stock price live, this page displays BME ALM stock exchange data. View the ALM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Almirall real time stock price chart below.
What Is the Almirall Stock Price Today?
The Almirall stock price today is 10.630.
What Is the Stock Symbol for Almirall?
The stock symbol for Almirall is ""ALM.""
What Stock Exchange Does Almirall Trade On?
Almirall is listed and trades on the Madrid stock exchange.
Is Almirall a Good Stock to Buy?
Determining whether Almirall—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALM quote. (ISIN: ES0157097017)
What Is the Almirall Stock Price Today?
The Almirall stock price today is 10.630.
What Is the Stock Symbol for Almirall?
The stock symbol for Almirall is ""ALM.""
What Stock Exchange Does Almirall Trade On?
Almirall is listed and trades on the Madrid stock exchange.
Is Almirall a Good Stock to Buy?
Determining whether Almirall—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALM quote. (ISIN: ES0157097017)
10.630
+0.050(+0.47%)
Real-time Data·
Fair Value
An estimate of a Almirall's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.590
10.670
52 wk Range
8.030
11.400
ALM Scorecard
Full Analysis
Net income is expected to grow this year
ALM is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Almirall's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.59010.670
52 wk Range
8.03011.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Almirall's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
12.900
Upside
+21.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Almirall Q1 2025 Results
- Investing.com
- Almirall SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Almirall SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Almirall SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Almirall Company Profile
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations. It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Almirall Earnings Call Summary for Q1/2025
- Q1 2025 net sales up 15% YoY to $284.6M, missing forecast by $2.68M; stock rose 7.82% pre-market
- European dermatology business expanded 23.4%; ILUMETRI and EGLIS showed strong growth
- EBITDA up 35% to $70.9M; R&D investment increased 34%, representing 12.5% of net sales
- Targeting double-digit net sales CAGR by 2023 and 25% EBITDA margin by 2028
- Planning four new Phase II clinical studies; exploring new indications for IL-thirteen treatments
Last Updated: 12/05/2025, 09:50
Read Full TranscriptCompare ALM to Peers and Sector
Metrics to compare | ALM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 93.7x | 16.4x | −0.5x | |
PEG Ratio | - | 0.04 | 0.00 | |
Price/Book | 1.5x | 3.9x | 2.6x | |
Price / LTM Sales | 2.2x | 3.6x | 3.2x | |
Upside (Analyst Target) | 18.4% | 18.5% | 42.7% | |
Fair Value Upside | Unlock | 15.4% | 5.8% | Unlock |
Analyst Ratings
7 Buy
3 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 12.900
(+21.35% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
0.10 / --
Revenue / Forecast
284.60M / 287.28M
People Also Watch
FAQ
What Stock Exchange Does Almirall Trade On?
Almirall is listed and trades on the Madrid Stock Exchange stock exchange.
What Is the Stock Symbol for Almirall?
The stock symbol for Almirall is "ALM."
What Is the Almirall Market Cap?
As of today, Almirall market cap is 2.28B.
What Is Almirall's Earnings Per Share (TTM)?
The Almirall EPS (TTM) is 0.11.
When Is the Next Almirall Earnings Date?
Almirall will release its next earnings report on 24 Jul 2025.
From a Technical Analysis Perspective, Is ALM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Almirall Stock Split?
Almirall has split 4 times.
How Many Employees Does Almirall Have?
Almirall has 2026 employees.
What is the current trading status of Almirall (ALM)?
As of 23 Jul 2025, Almirall (ALM) is trading at a price of 10.63, with a previous close of 10.58. The stock has fluctuated within a day range of 10.59 to 10.67, while its 52-week range spans from 8.03 to 11.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.